Griffith joins the fight against pneumonia

November 10, 2013

Advancing the fight against pneumonia is the focus of a new online scholarly journal launched by Griffith University ePress.

With an aim to establish an international forum on this deadly disease, pneumonia.org.au is a peer-reviewed, open-access journal which brings together knowledge related to its pathogenesis, treatment and prevention.

Griffith's Professor Allan Cripps is the Editor in Chief of pneumonia, which features original research articles, case studies, reviews, critical commentaries, correspondence, highlights and news on all aspects of the disease.

"Pneumonia is the leading cause of death in children worldwide and kills an estimated 1.2 million children under the age of five every year," says Professor Cripps during the lead up to this year's World Pneumonia Day (November 12).

"Relatively few resources have been committed to addressing the problem of childhood pneumonia, particularly in resource-poor settings.

"However we are starting to see some fantastic support from organisations such as the GAVI Alliance which has assisted over 20 countries to introduce the pneumococcal conjugate vaccine which prevents the most common form of childhood pneumonia.

"And we have also seen unprecedented investment by the Bill and Melinda Gates Foundation to support the research, development and delivery of life-saving vaccines for the world's poorest countries.

"Pneumonia is part of this overall pledge to raise the global profile of this forgotten killer and advance the fight against childhood mortality."

As the only scientific journal exclusively focused on the disease, pneumonia is starting to gain some momentum. The journal is now publishing in its second volume and has so far received over 20,000 page visits from every continent across 100 countries."

It has also been chosen as the assigned journal for the 9th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-9) in Hyderabad, March 9-13, 2014.

"Now the journal is moving towards Scopus and PubMed listing in order to raise the profile of the disease amongst the academic community," says Professor Cripps.

The Editorial Board of pneumonia currently consists of 25 international members who are leading researchers from around the world.

"This international collaboration is particularly important for attracting researchers and authors from developing countries, as I am aware that authors from these areas find it difficult to pay the associated costs of publication to most scientific journals."

There are no fees for the submission of manuscripts to pneumonia.org.au, nor any costs associated with their publication or access online.
-end-
pneumonia.org.au is proud to support World Pneumonia Day. Established in 2009, it aims to raise awareness about pneumonia, promote interventions to protect against, prevent and treat pneumonia and to generate action in combating the disease. Please visit the website http://worldpneumoniaday.org/ and support this fantastic initiative.

Griffith University

Related Pneumonia Articles from Brightsurf:

Vaccine proves effective against the most severe type of pneumonia
A pneumococcal vaccine was effective at protecting children in Laos against the most severe type of pneumonia, a new study has found.

Osteoporosis treatment may also protect against pneumonia
A recent study published in the Journal of Bone and Mineral Research found that nitrogen-containing bisphosphonates (N-BPs) such as alendronate, which are widely used to treat postmenopausal osteoporosis, are linked with lower risks of pneumonia and of dying from pneumonia.

Elderly patients with pneumonia twice as likely to die as those with broken hips, yet underestimate the danger of pneumonia
Elderly patients who are hospitalised with pneumonia are twice as likely to die as those hospitalised with hip fractures -- yet many elderly people fail to accurately assess their risk of pneumonia, concludes research due to be presented at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

Pneumonia recovery reprograms immune cells of the lung
Researchers have determined that after lungs recover from infection, alveolar macrophages (immune cells that live in the lungs and help protect the lungs against infection) are different in multiple ways and those differences persist indefinitely.

Skin and mucous membrane lesions as complication of pneumonia
Painful inflammatory lesions of the skin and mucous membranes may occur in children who develop bacterial pneumonia.

Vaccine reduces likelihood of severe pneumonia
A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

Bacteria in pneumonia attack using bleaching agent
Research shows that bacteria use hydrogen peroxide to weaken the immune system and cause pneumonia.

Many kids with pneumonia get unnecessary antibiotics, chest X-rays
Preschool children with community-acquired pneumonia often receive unnecessary tests and treatment at outpatient clinics and emergency departments, according to a nationally representative study led by Todd Florin, M.D., MSCE, from Ann & Robert H.

Certain psychiatric drugs linked with elevated pneumonia risk
A review of published studies indicates that use of benzodiazepines and benzodiazepine related drugs (BZRDs), which are prescribed to treat various psychiatric diseases, may increase the risk of pneumonia.

Bacterial pneumonia far more dangerous to the heart than viral pneumonia, study finds
Heart complications in patients diagnosed with bacterial pneumonia are more serious than in patients diagnosed with viral pneumonia, according to new research.

Read More: Pneumonia News and Pneumonia Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.